Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase? - Digital Cluster of Scitech Periodicals

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?

DOI: 10.4103/1673-5374.226389

Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?

Benoit Souchet

Mickael Audrain

Baptiste Billoir

Laurent Lecanu

Satoru Tada

Jér?me Braudeau

Machine-generated Keywords：

Publication Date：2018-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：2( 224-225 )

Neural Regeneration Research

Neural Regeneration Research

ISTICSCI

ISSN：1673-5374

Year, Vol.(Issue)：2018,13(2)